DermTech, LLC Secures 28,869-Square-Foot Lease for New Headquarters and Laboratory in San Diego with JLL's Representation

Reuters
Aug 06
DermTech, LLC Secures 28,869-<a href="https://laohu8.com/S/XYZ">Square</a>-Foot Lease for New Headquarters and Laboratory in San Diego with JLL's Representation

Jones Lang LaSalle Inc. $(JLL)$ has successfully facilitated a significant real estate transaction for DermTech, LLC, a newly formed leader in precision dermatology. On June 27, 2025, JLL announced that they represented DermTech in securing a 28,869-square-foot lease at 12340 El Camino Real in San Diego, California. The space will serve as DermTech's headquarters and laboratory, aligning with the company's goals and culture while optimizing costs in a top-quality molecular lab environment. This new facility, located at Kilroy's Del Mar Corporate Center in San Diego's Del Mar Heights neighborhood, is set to enhance DermTech's capabilities in offering non-invasive skin genomics solutions, particularly their DermTech Melanoma Test. JLL's team, including Grant Schoneman, Chad Urie, Taylor DeBerry, and Stephanie MacLeod, represented DermTech, while the landlord, Kilroy Realty, was represented by Brett Ward, Michael Cassolato, and Evan Cassolato of Cushman & Wakefield.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jones Lang LaSalle Inc. published the original content used to generate this news brief on August 05, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10